Allergan is looking hard at Asia for potential deals covering areas from intellectual property to outright M&A.

AnGes will end a major international Phase III study on peripheral artery diseases gene therapy candidate Collategene, citing high costs and a refocus of…

Prospects for higher foreign portfolio and overseas company investment in Indian drug firms brightened as the government moved to raise the direct shareholding…

China health clinic operator iKang remains in play even after an offer earlier this month that suggested a Jack Ma-linked investment firm had won a bidding war.

Terumo scoops up Sequent Medical for $375M

Dr. Reddy's snaps up Teva products in U.S. sold as part of Allergan deal.

Biosimilar firms in Asia are in focus for Novartis CEO Joe Jimenez as he seeks to find a complement to programs by the drugmaker's generic arm Sandoz in…

India's Commerce and Industry Ministry plans to measure the impact of foreign investment on the drug industry in a step that will be closely watched for…